Raynovent Announces Receiving of Certificate of Invention Patent in Russia

Time:2019.07.16Views:86Author:众生睿创

Raynovent received the Certificate of Invention Patent (Hydroxyl purine compounds and applications) issued by Federal Service for Intellectual Property (Russia).

Previous:Raynovent Announces Receiving of Certificate of Invention Patent

Next:Dr. Chen Xiaoxin, Vice President of Raynovent was Appointed as Vice President of China Non-alcoholic Steatohepatitis New Drug Alliance

News Center